Male breast cancer: A population-based comparison with female breast cancer

Journal of Clinical Oncology

Volumn 28, Issue 2, 2010, Pages 232-239

  Anderson, William F ^a   Jatoi, Ismail ^a   Tse, Julia ^a   Rosenberg, Philip S ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE BREAST; POPULATION RESEARCH; PRIORITY JOURNAL; RARE DISEASE; SEX DIFFERENCE; ADOLESCENT; AGE; AGE DISTRIBUTION; BREAST TUMOR; CANCER REGISTRY; CHILD; COMPARATIVE STUDY; INCIDENCE; METABOLISM; MIDDLE AGED; MORTALITY; NEOPLASM; RISK FACTOR; SURVIVAL; TIME; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CHILD; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, ESTROGEN; RISK FACTORS; SEER PROGRAM; SURVIVAL ANALYSIS; TIME FACTORS; UNITED STATES;

EID: 74949102413     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.23.8162     Document Type: Article

References (52)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58:71-96, 2008
2. Tischkowitz MD, Hodgson SV, Fentiman IS: 19. Male breast cancer: Aetiology, genetics and clinical management. Int J Clin Pract 56:750-754, 2002
3. Giordano SH: Male breast cancer: It's time for evidence instead of extrapolation. Onkologie 31:505-506, 2008
4. English JC 3rd, Middleton C, Patterson JW, et al: Cancer of the male breast. Int J Dermatol 39:881-886, 2000
5. Berry DA, Ravdin PM: Breast cancer trends: A marriage between clinical trial evidence and epidemiology. J Natl Cancer Inst 99:1139-1141, 2007
6. Hodgson NC, Button JH, Franceschi D, et al: Male breast cancer: Is the incidence increasing? Ann Surg Oncol 11:751-755, 2004
7. Giordano SH, Cohen DS, Buzdar AU, et al: Breast carcinoma in men: A population-based study. Cancer 101:51-57, 2004
8. Fentiman IS, Fourquet A, Hortobagyi GN: Male breast cancer. Lancet 367:595-604, 2006
9. Stang A, Thomssen C: Decline in breast cancer incidence in the United States: What about male breast cancer? Breast Cancer Res Treat 112:595-596, 2008
10. Contractor KB, Kaur K, Rodrigues GS, et al: Male breast cancer: Is the scenario changing. World J Surg Oncol 6:58, 2008
11. Anderson WF, Althuis MD, Brinton LA, et al: Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 83:77-86, 2004
12. Pant K, Dutta U: Understanding and management of male breast cancer: A critical review. Med Oncol 25:294-298, 2008
13. Giordano SH, Buzdar AU, Hortobagyi GN: Breast cancer in men. Ann Intern Med 137:678-687, 2002
14. Moolgavkar SH, Lee JA, Hade RD: Comparison of age-specific mortality from breast cancer in males in the United States and Japan. J Natl Cancer Inst 60:1223-1225, 1978
15. Ewertz M, Holmberg L, Karjalainen S, et al: Incidence of male breast cancer in Scandinavia, 1943-1982. Int J Cancer 43:27-31, 1989
16. Goodman MT, Tung KH, Wilkens LR: Comparative epidemiology of breast cancer among men and women in the US, 1996 to 2000. Cancer Causes Control 17:127-136, 2006
17. SEER-9: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 9 Regs Limited-Use, Nov 2007 Sub (1973-2005) < Single Ages to 85+, Katrina/Rita Population Adjustment > -Linked To County Attributes - Total U.S., 1969-2005 Counties, National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on November 2007 submission
18. SEER-13: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 13 Regs Limited-Use, Nov 2007 Sub (1973-2005) < Single Ages to 85+, Katrina/Rita Population Adjustment > -Linked To County Attributes - Total U.S., 1969-2005 Counties, National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on November 2007 submission
19. SEER-17: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer .gov) SEER*Stat Database: Incidence-SEER 17 Regs Limited-Use, Nov 2007 Sub (1973-2005) < Single Ages to 85+, Katrina/Rita Population Adjustment > -Linked To County Attributes - Total U.S., 1969-2005 Counties, National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on November 2007 submission
20. SEER: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Mortality - All Cause of Death, Total U.S. (1969-2005) < Single Ages to 85+, Katrina/Rita Population Adjustment > -Linked To County Attributes - Total U.S., 1969-2005 Counties, National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released February 2008. Underlying mortality data provided by the NCHS (www.cdc.gov/nchs), 2008
21. Devesa SS, Donaldson J, Fears T: Graphical presentation of trends in rates. Am J Epidemiol 141:300-304, 1995
22. Kim HJ, Fay MP, Feuer EJ, et al: Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335-351, 2000
23. Holford TR: The estimation of age, period and cohort effects for vital rates. Biometrics 39:311-324, 1983
24. Clayton D, Schifflers E: Models for temporal variation in cancer rates: II. Age-period-cohort models. Stat Med 6:469-481, 1987
25. Clayton D, Schifflers E: Models for temporal variation in cancer rates: I. Age-period and agecohort models. Stat Med 6:449-467, 1987
26. Holford TR: Age-period-cohort analysis, in Armitage P, Colton T (eds): Encyclopedia of Biostatistics. Chichester, England, John Wiley & Sons, 1998, pp 82-99
27. Anderson WF, Rosenberg PS, Menashe I, et al: Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst 100:1804-1814, 2008
28. Anderson WF: Cancer surveillance research. Cancer Epidemiol Biomarkers Prev 18:1669-1671, 2009
29. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
30. Breslow NE, Lubin JH, Marek P, et al: Multiplicative models and cohort analysis. J Am Stat Assoc 78:1-12, 1983
31. Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer: Interim analysis at four years by Nolvadex Adjuvant Trial Organisation. Lancet 1:257-261, 1983
32. Clemmesen J: Carcinoma of the breast: Results from statistical research. Br J Radiol 21:583-590, 1948
33. Thomas DB: Breast cancer in men. Epidemiol Rev 15:220-231, 1993
34. de Waard F: Premenopausal and postmenopausal breast cancer: One disease or two? J Natl Cancer Inst 63:549-552, 1979
35. Perou CM, Sorlie T, Eisen MB, et al: Molecular portraits of human breast tumours. Nature 406:747-752, 2000
36. Sørlie T, Wang Y, Xiao C, et al: Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: Gene expression analyses across three different platforms. BMC Genomics 7:127, 2006
37. Anderson WF, Pfeiffer RM, Dores GM, et al: Comparison of age frequency distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 15:1899-1905, 2006
38. Fox MS: On the diagnosis and treatment of breast cancer. JAMA 241:489-494, 1979
39. Evans DB, Crichlow RW: Carcinoma of the male breast and Klinefelter's syndrome: Is there an association? CA Cancer J Clin 37:246-251, 1987
40. Sasco AJ, Lowenfels AB, Pasker-de Jong P: Review article: Epidemiology of male breast cancer - A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 53:538-549, 1993
41. Basham VM, Lipscombe JM, Ward JM, et al: BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 4:R2, 2002
42. Hultborn R, Hanson C, Köpf I, et al: Prevalence of Klinefelter's syndrome in male breast cancer patients. Anticancer Res 17:4293-4297, 1997
43. Friedman LS, Gayther SA, Kurosaki T, et al: Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 60:313-319, 1997
44. Ottini L, Rizzolo P, Zanna I, et al: BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: A population-based study in central Italy. Breast Cancer Res Treat 116:577-586. 2009
45. Berry DA, Cronin KA, Plevritis SK, et al: Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353:1784-1792, 2005
46. Ravdin PM, Cronin KA, Howlader N, et al: The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356:1670-1674, 2007
47. Jatoi I, Chen BE, Anderson WF, et al: Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 25:1683-1690, 2007
48. Mariotto A, Feuer EJ, Harlan LC, et al: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. J Natl Cancer Inst 94:1626-1634, 2002
49. Ribeiro G, Swindell R: Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer 65:252-254, 1992
50. Vetto J, Jun SY, Paduch D, et al: Stages at presentation, prognostic factors, and outcome of breast cancer in males. Am J Surg 177:379-383, 1999
51. Giordano SH, Perkins GH, Broglio K, et al: Adjuvant systemic therapy for male breast carcinoma. Cancer 104:2359-2364, 2005
52. Anelli TF, Anelli A, Tran KN, et al: Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients. Cancer 74:74-77, 1994